Praxis Precision Medicines, Inc. Common Stock

Go to Praxis Precision Medicines, Inc. Common Stock Website

$47.79

0.00 (0.00%)
Live
Previous Close

$47.79

Day Range

$0 - $0

Previous Day Range

$46.575 - $53.46

Market Cap

$1.0 billion USD

Day Vol.

0

Previous Day Vol.

865819

Currency

USD

Primary Exchange

Nasdaq

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Praxis Precision Medicines announced a virtual fireside chat and highlighted positive results from their RADIANT study on vormatrigine, demonstrating a 56.3% median reduction in seizure frequency for focal onset seizure patients.

Related tickers: PRAX.

Read Full Article

Praxis Precision Medicines reported a wider Q2 2025 loss of ($3.31) per share, with no revenue and doubled research expenses. The company continues advancing clinical trials for neurological disorder treatments, with promising results in epilepsy drug vormatrigine and receiving Breakthrough Therapy Designation for relutrigine.

Related tickers: PRAX.

Read Full Article
Trending Tickers

Please sign in to view